Abstract:Classical swine fever virus (CSFV) is the causative agent of classical swine fever, a notifiable disease of economic importance that causes severe leukopenia, fever and haemorrhagic disease in domesticated pigs and wild boar across the globe. CSFV has been shown to antagonise the induction of type I IFN, partly through a function of its N-terminal protease (Npro) which binds IRF3 and targets it for proteasomal degradation. Additionally, Npro has been shown to antagonise apoptosis triggered by the dsRNA-homolog… Show more
“…Having observed strain dependent differences in the expression of IFN-a, we thought it necessary to investigate the type I IFN response in PRRSV-1 infected BMDM. We have previously demonstrated that dsRNA and SeV are specific agonists of TLR-3 and RIG-I mediated type I IFN responses in porcine cells, respectively (37). When utilized in BMDM, both ligands induced strong expression of the ISGs, Mx1, ISG15 and RIG-I.…”
Section: Discussionmentioning
confidence: 96%
“…Western blots were performed as previously described (37). Primary antibodies; Anti-RIG-I (Santa Cruz, Dallas, US #sc-376845), Anti-Mx1 (GeneTex, Hsinchu City 300 Taiwan, R.O.C., #GTX110256), Anti-ISG15 (Abcam, Cambridge, UK, #ab233071), Anti-g-tubulin (Merck, #T6557) were used where indicated.…”
Section: Western Blot Analysismentioning
confidence: 99%
“…Having observed that infection with virulent SU1-Bel induced significantly higher expression of IFN-a compared to the less virulent 215-06 and Olot/91 strains, we postulated that this may lead to a higher expression of type I IFN stimulated genes (ISG). We have previously validated the expression of Mx1, RIG-I and ISG15 as markers of ISG expression in immortalized porcine cells (37) and applied this methodology to investigate ISG expression in the porcine BMDM. To facilitate this, BMDM from three animals were infected (MOI 0.01) with either SU1-Bel, 215-06 or Olot/91 and at 48 hpi whole cell lysates were prepared and analyzed for expression of Mx1, RIG-I and ISG15 by Western blot (Figure 4).…”
Section: Attenuated Prrsv-1 Induces Higher Expression Of Interferon S...mentioning
Porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) causes huge economic losses to the European pig industry. PRRSV-1 is divided into 3 subtypes and exhibits considerable antigenic heterogeneity. Due to its high mutation rate, PRRSV-1 is constantly evolving, and highly virulent, particularly subtype 3 strains, are continually emerging. The mechanism(s) underlying PRRSV-1 virulence have not been fully elucidated. In vivo studies have implicated replication kinetics, cell tropism and an enhanced pro-inflammatory cytokine response as potential contributing factors. However, few strains have been directly compared and differences in in vivo study design have hindered comparison, thus limiting our understanding of PRRSV-1 virulence. To address this knowledge gap, we sought to develop a reverse genetics and ex vivo model system, to attempt to identify correlates of PRRSV-1 virulence and attenuation in vitro. Herein we describe the use of primary porcine bone marrow-derived macrophages (BMDM) to investigate the growth kinetics and induced cytokine profiles of the highly virulent SU1-Bel strain, the low virulence 215-06 strain and the attenuated Olot/91 strain. We show that infection of BMDM with virulent PRRSV-1 strains induced higher expression of IL-6 and IL-8 and lower expression of TNF-α when compared with the attenuated strain. In addition, BMDM infected with SU1-Bel secreted significantly more IFN-α than those infected with PRRSV-1 strains of lower virulence. Interestingly, despite inducing less IFN-α than SU1-Bel, Olot/91 induced much higher levels of expression of several interferon-stimulated genes (ISGs), suggesting that Olot/91 may be less able to counteract type I IFN signaling which may contribute to its attenuated phenotype.
“…Having observed strain dependent differences in the expression of IFN-a, we thought it necessary to investigate the type I IFN response in PRRSV-1 infected BMDM. We have previously demonstrated that dsRNA and SeV are specific agonists of TLR-3 and RIG-I mediated type I IFN responses in porcine cells, respectively (37). When utilized in BMDM, both ligands induced strong expression of the ISGs, Mx1, ISG15 and RIG-I.…”
Section: Discussionmentioning
confidence: 96%
“…Western blots were performed as previously described (37). Primary antibodies; Anti-RIG-I (Santa Cruz, Dallas, US #sc-376845), Anti-Mx1 (GeneTex, Hsinchu City 300 Taiwan, R.O.C., #GTX110256), Anti-ISG15 (Abcam, Cambridge, UK, #ab233071), Anti-g-tubulin (Merck, #T6557) were used where indicated.…”
Section: Western Blot Analysismentioning
confidence: 99%
“…Having observed that infection with virulent SU1-Bel induced significantly higher expression of IFN-a compared to the less virulent 215-06 and Olot/91 strains, we postulated that this may lead to a higher expression of type I IFN stimulated genes (ISG). We have previously validated the expression of Mx1, RIG-I and ISG15 as markers of ISG expression in immortalized porcine cells (37) and applied this methodology to investigate ISG expression in the porcine BMDM. To facilitate this, BMDM from three animals were infected (MOI 0.01) with either SU1-Bel, 215-06 or Olot/91 and at 48 hpi whole cell lysates were prepared and analyzed for expression of Mx1, RIG-I and ISG15 by Western blot (Figure 4).…”
Section: Attenuated Prrsv-1 Induces Higher Expression Of Interferon S...mentioning
Porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) causes huge economic losses to the European pig industry. PRRSV-1 is divided into 3 subtypes and exhibits considerable antigenic heterogeneity. Due to its high mutation rate, PRRSV-1 is constantly evolving, and highly virulent, particularly subtype 3 strains, are continually emerging. The mechanism(s) underlying PRRSV-1 virulence have not been fully elucidated. In vivo studies have implicated replication kinetics, cell tropism and an enhanced pro-inflammatory cytokine response as potential contributing factors. However, few strains have been directly compared and differences in in vivo study design have hindered comparison, thus limiting our understanding of PRRSV-1 virulence. To address this knowledge gap, we sought to develop a reverse genetics and ex vivo model system, to attempt to identify correlates of PRRSV-1 virulence and attenuation in vitro. Herein we describe the use of primary porcine bone marrow-derived macrophages (BMDM) to investigate the growth kinetics and induced cytokine profiles of the highly virulent SU1-Bel strain, the low virulence 215-06 strain and the attenuated Olot/91 strain. We show that infection of BMDM with virulent PRRSV-1 strains induced higher expression of IL-6 and IL-8 and lower expression of TNF-α when compared with the attenuated strain. In addition, BMDM infected with SU1-Bel secreted significantly more IFN-α than those infected with PRRSV-1 strains of lower virulence. Interestingly, despite inducing less IFN-α than SU1-Bel, Olot/91 induced much higher levels of expression of several interferon-stimulated genes (ISGs), suggesting that Olot/91 may be less able to counteract type I IFN signaling which may contribute to its attenuated phenotype.
“…Viruses often evade the immune response by antagonizing specific pathways. Numerous viral proteins have been shown to antagonize the transcriptional and the RIPA activity of IRF3 ( 80 – 82 ). It is also tempting to speculate the viruses have coevolved to evade specific functions of IRF3, and the host can fight back using the additional options.…”
Interferon (IFN) regulatory factor 3 (IRF3) is a transcription factor activated by phosphorylation in the cytoplasm of a virus-infected cell; by translocating to the nucleus, it induces transcription of IFN-β and other antiviral genes. We have previously reported IRF3 can also be activated, as a proapoptotic factor, by its linear polyubiquitination mediated by the RIG-I pathway. Both transcriptional and apoptotic functions of IRF3 contribute to its antiviral effect. Here, we report a nontranscriptional function of IRF3, namely, the repression of IRF3-mediated NF-κB activity (RIKA), which attenuated viral activation of NF-κB and the resultant inflammatory gene induction. In
Irf3
−/−
mice, consequently, Sendai virus infection caused enhanced inflammation in the lungs. Mechanistically, RIKA was mediated by the direct binding of IRF3 to the p65 subunit of NF-κB in the cytoplasm, which prevented its nuclear import. A mutant IRF3 defective in both the transcriptional and the apoptotic activities was active in RIKA and inhibited virus replication. Our results demonstrated IRF3 deployed a three-pronged attack on virus replication and the accompanying inflammation.
“…In addition, STING is a target for HCV-NS4B to block RIG-I-mediated activation of IFN-β production by blocking its interaction with MAVS. NS4B and STING are localized on ER and MAM [139]. MAM-resident factor Gp78 was also found to be involved in innate antiviral signaling by targeting MAVS during vesicular stomatitis virus (VSV) infection [140].…”
Abnormal function of suborganelles such as mitochondria and endoplasmic reticulum often leads to abnormal function of cardiomyocytes or vascular endothelial cells and cardiovascular disease (CVD). Mitochondria-associated membrane (MAM) is involved in several important cellular functions. Increasing evidence shows that MAM is involved in the pathogenesis of CVD. MAM mediates multiple cellular processes, including calcium homeostasis regulation, lipid metabolism, unfolded protein response, ROS, mitochondrial dynamics, autophagy, apoptosis, and inflammation, which are key risk factors for CVD. In this review, we discuss the structure of MAM and MAM-associated proteins, their role in CVD progression, and the potential use of MAM as the therapeutic targets for CVD treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.